Krüppel-like factor 4 expression in oral carcinoma cells and hypermethylation at the gene promoter

Ayumi Yamaguchi1, Karen Kuroyama2, Ayana Tokura3

  • 1School of Life Dentistry at Tokyo, The Nippon Dental University, 1-9-20, Chiyoda-ku, Fujimi, Tokyo, 102-8159, Japan. ayumi.y.ii.may.seven1@gmail.com.

BMC Oral Health
|February 6, 2016
PubMed
Abstract

Insights

Hypermethylation of the Krüppel-like factor 4 (KLF4) gene promoter in oral carcinoma cells leads to low KLF4 expression. This silencing contributes to oral cancer progression.

Area of Science:

  • Molecular Biology
  • Oncology
  • Epigenetics

Background:

  • Krüppel-like factor 4 (KLF4) is a key transcription factor involved in epithelial cell proliferation and differentiation.
  • KLF4 is often downregulated in advanced oral carcinomas, suggesting a role in oral cancer development.
  • The mechanism of KLF4 inactivation in oral carcinoma cells, particularly promoter methylation, was previously unclear.

Purpose of the Study:

  • To investigate the methylation status of the KLF4 gene promoter in oral carcinoma cell lines.
  • To determine the correlation between KLF4 promoter methylation and KLF4 expression levels.
  • To assess the impact of demethylation on KLF4 expression in oral cancer cells.

Main Methods:

  • Genomic DNA from oral carcinoma cell lines and normal keratinocytes was analyzed for KLF4 promoter methylation using bisulfite sequencing.
  • KLF4 mRNA and protein expression were quantified using real-time PCR and immunoblotting, respectively.
  • Cells were treated with a demethylation reagent to observe effects on KLF4 expression.

Main Results:

  • Hypermethylation was observed in a specific promoter region (-718 to -482) of the KLF4 gene in oral carcinoma cells with low KLF4 expression.
  • This promoter region was infrequently methylated in cells expressing high KLF4 levels.
  • Demethylation treatment significantly increased both KLF4 mRNA and protein levels.

Conclusions:

  • Hypermethylation of a specific KLF4 promoter region is a mechanism for KLF4 gene silencing in oral carcinoma.
  • Downregulation of KLF4 expression due to promoter hypermethylation likely contributes to the progression of oral cancer.
  • Restoring KLF4 expression through demethylation offers potential therapeutic insights for oral cancer treatment.

Related Concept Videos

Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
34.2K
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
4.2K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
Somatic to iPS Cell Reprogramming01:29

Somatic to iPS Cell Reprogramming

Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.8K
Methods of Nuclear Reprogramming01:24

Methods of Nuclear Reprogramming

Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
2.2K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
6.2K